Overview
Etienne Chatelut practices in Toulouse, France. Mr. Chatelut is rated as a Distinguished expert by MediFind in the treatment of Dihydropyrimidine Dehydrogenase Deficiency. His top areas of expertise are Dihydropyrimidine Dehydrogenase Deficiency, Colorectal Cancer, Thrombocytopenia, and Renal Cell Carcinoma (RCC).
His clinical research consists of co-authoring 118 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 6 articles in the study of Dihydropyrimidine Dehydrogenase Deficiency.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Dihydropyrimidine Dehydrogenase DeficiencyMr. Chatelut isDistinguished. Learn about Dihydropyrimidine Dehydrogenase Deficiency.
- Experienced
- Adrenocortical CarcinomaMr. Chatelut isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Soft Tissue SarcomaMr. Chatelut isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisMr. Chatelut isExperienced. Learn about Agranulocytosis.
- Breast CancerMr. Chatelut isExperienced. Learn about Breast Cancer.
- Chronic B-Cell Leukemia (CBCL)Mr. Chatelut isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Mr. Chatelut isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).